表紙
市場調査レポート

欧州の遺伝病・癌・法医学・実父確定の分子診断検査市場:国別予測、新興の技術、競合情勢

2016-2020 Europe Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Strategies

発行 Venture Planning Group 商品コード 309614
出版日 ページ情報 英文 495 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=105.42円で換算しております。

Local License: 同一事業所内

Back to Top
欧州の遺伝病・癌・法医学・実父確定の分子診断検査市場:国別予測、新興の技術、競合情勢 2016-2020 Europe Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Strategies
出版日: ページ情報: 英文 495 Pages
概要

当レポートでは、欧州の主要5ヶ国における遺伝病・癌・法医学・実父確定/HLA型の分子診断検査について調査分析し、新興の分子診断技術や製品に焦点を当てて、国別の現状と将来予測のほか、主要製品の開発機会、市場参入戦略、主要企業などについて、体系的な情報を提供しています。

イントロダクション

世界市場の動向と新興の技術

  • DNAシーケンシング
  • DNA・RNAプローブ技術
  • 検出技術
  • 検査装置:自動/半自動分析装置のレビュー
  • バイオチップ:ゲノセンサー、マイクロアレイ、ラボオンチップ
  • ファーマコゲノミクス
  • 癌の分子診断検査
  • 遺伝病の分子診断検査
  • 法医学の分子診断検査
  • 実父確定検査/HLA型分子診断検査
  • その他の分子診断検査の応用
  • 競合/補完技術

フランス

  • エグゼクティブサマリー
  • ビジネス環境
  • 市場構造
  • 市場力学、動向、規模、成長率

ドイツ

  • エグゼクティブサマリー
  • ビジネス環境
  • 市場構造
  • 市場力学、動向、規模、成長率

イタリア

  • エグゼクティブサマリー
  • ビジネス環境
  • 市場構造
  • 市場力学、動向、規模、成長率

スペイン

  • エグゼクティブサマリー
  • ビジネス環境
  • 市場構造
  • 市場力学、動向、規模、成長率

英国

  • エグゼクティブサマリー
  • ビジネス環境
  • 市場構造
  • 市場力学、動向、規模、成長率

主要製品の開発機会

  • 装置
  • 試薬キットと検査システム/パネル
  • IT、コンピューター、ソフトウェア、オートメーション
  • 補助製品

分散型検査製品の設計基準

代替的な市場普及戦略

潜在的な市場参入障壁とリスク

競合企業プロファイル

  • Abbott
  • Affymetrix
  • Agilent Technologies
  • Applied Gene Technologies
  • Arca/Nuvelo
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biokit
  • BioMerieux
  • Bio-Rad
  • Biotest
  • Caliper
  • Cepheid
  • Decode
  • Diadexus
  • 栄研化学
  • Enzo
  • Exact Sciences
  • 富士レビオ/Innogenetics
  • Grifols
  • Hologic/Gen-Probe
  • Illumina
  • Kreatech
  • Li-Cor Biosciences
  • Life Technologies/Thermo Fisher
  • Monogram Biosciences
  • Myriad Genetics
  • Nanogen/Elitech
  • Orchid CellMark
  • Ortho-Clinical Diagnostics
  • Proteome Sciences
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • Shimadzu
  • Siemens
  • Sierra Molecular
  • タカラバイオ
  • Tecan Group

付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: VPMD18306

The report is available by country, section, market segment, and can be custom-tailored to your specific information needs and budget.

This new five-country study from VPGMarketResearch contains 495 pages, 28 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the next five years.

Report Highlights

- Market shares of leading suppliers Business and technological trends in major markets Five-year test volume and sales forecasts Market shares of leading competitors Feature comparison of major analyzers Strategic profiles of leading market players and start-up firms developing innovative products Specific product and business opportunities for instrument and consumable suppliers.

Rationale

Genetic Diseases, Cancer, Forensic and Paternity molecular diagnostic testing markets are among the most rapidly growing segments of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. In order to successfully capitalize on the opportunities presented by these markets, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.

Geographic Coverage

- France Germany Italy Spain UK

European Market Overview

- Laboratories performing DNA sequencing and molecular diagnostic testing by country and market segment.

- Five-year test volume and sales projections by country.

Market Segmentation Analysis

- Five-year test volume and sales projections:

- Infectious Diseases        - Forensic Testing
Cancer                            - Paternity Testing/HLA Typing
Genetic Diseases            - Others

- A comprehensive analysis of the sequencing market by country and laboratory segment.

- Detailed market segmentation analysis, including review of the market dynamics, trends,   structure, size, growth and major suppliers by country.

Product/Technology Review

- Comparison of the major molecular diagnostic analyzers.

- Extensive review of molecular diagnostic technologies, test formats, detection methodologies,   trends in testing automation and over target/signal amplification methods.

- Worldwide listings of companies, universities and research centers developing new molecular    diagnostic technologies and products.

Competitive Assessments

- Extensive strategic assessments of major suppliers and emerging market entrants,   including their sales, product portfolios, marketing tactics, collaborative arrangements and   new technologies/products in R&D.

   - Abbott    - Affymetrix    - Agilent Technologies    - Applied Gene Technologies    - Arca Biopharma    - Beckman Coulter/Danaher    - Becton Dickinson    - Biokit    - BioMerieux    - Bio-Rad    - Biotest    - CellMark Forensics/LabCorp    - Cepheid    - Decode Genetics    - Diadexus    - Eiken    - Elitech Group    - Enzo    - Exact Sciences    - Fujirebio    - Grifols    - Hologic/Gen-Probe    - Illumina    - Kreatech/Leica    - Li-Cor Biosciences    - Monogram Biosciences    - Myriad Genetics    - Ortho-Clinical Diagnostics    - Perkin Elmer/Caliper    - Proteome Sciences    - Qiagen    - Roche    - Scienion    - Sequenom    - Shimadzu    - Siemens    - Sierra Molecular    - Takara Bio    - Tecan Group    - Thermo Fisher

- Comprehensive listings of companies developing and marketing molecular   diagnostic products, by test and application.

Opportunities and Strategic Recommendations

- Specific new product development opportunities with potentially significant market appeal   during the next five years.

- Design criteria for new products.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

- Business planning issues and concerns.

Contains 495 pages and 28 tables

Table of Contents

Introduction

Global Market Trends and Emerging Technologies

  • A. DNA Sequencing
  • B. DNA and RNA Probe Technology
  • C. Detection Technologies
  • D. Instrumentation: Review of Automated and Semi-Automated Analyzers
  • E. Biochips: Genosensors, Microarrays, Labs-on-the-Chip
  • F. Pharmacogenomics
  • G. Cancer Molecular Diagnostics Testing
    • 1. Overview
    • 2. Major Cancer Types
    • 3. Oncogenes
  • H. Genetic Diseases Molecular Diagnostic Testing
    • 1. Overview
    • 2. Nucleic Acid Amplification
    • 3. Chromosome Imaging
    • 4. Genomics Technologies
    • 5. Proteomics Technologies
    • 6. Current Pharmacogenomic Testing
    • 7. Major Diseases
  • I. Forensic Molecular Diagnostics Testing
    • 1. Overview
    • 2. Multilocus and Single Locus Probes
    • 3. The FBI
    • 4. DNA Profile Data Banks
    • 5. Judicial Implementation
    • 6. Major Crime Categories
    • 7. Factors Contributing to the DNA Probe Major Expansion
  • J. Paternity Testing/HLA Typing Molecular Diagnostic Testing
  • K. Other Molecular Diagnostic Testing Applications
  • L. Competing/Complementing Technologies

France

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Dynamics, Trends, Size and Growth
    • Volume Forecasts by Market Segment
    • Sales Forecasts by Market Segment
    • Major Supplier Sales and Market Shares

Germany

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Dynamics, Trends, Size and Growth
    • Volume Forecasts by Market Segment
    • Sales Forecasts by Market Segment
    • Major Supplier Sales and Market Shares

Italy

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Dynamics, Trends, Size and Growth
    • Volume Forecasts by Market Segment
    • Sales Forecasts by Market Segment
    • Major Supplier Sales and Market Shares

Spain

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Dynamics, Trends, Size and Growth
    • Volume Forecasts by Market Segment
    • Sales Forecasts by Market Segment
    • Major Supplier Sales and Market Shares

U.K.

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Dynamics, Trends, Size and Growth
    • Volume Forecasts by Market Segment
    • Sales Forecasts by Market Segment
    • Major Supplier Sales and Market Shares

Major Product Development Opportunities

  • A. Opportunities for New Instrumentation
  • B. Opportunities for New Reagent Kits and Test Systems/Panels
  • C. Opportunities for New IT, Computers, Software and Automation
  • D. Opportunities for New Auxiliary Products

Design Criteria For Decentralized Testing Products

Alternative Market Penetration Strategies

Potential Market Entry Barriers And Risks

Competitive Profiles

  • Abbott
  • Affymetrix
  • Agilent Technologies
  • Applied Gene Technologies
  • Arca/Nuvelo
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biokit
  • BioMerieux
  • Bio-Rad
  • Biotest
  • Caliper
  • Cepheid
  • Decode
  • Diadexus
  • Eiken
  • Enzo
  • Exact Sciences
  • Fujirebio/Innogenetics
  • Grifols
  • Hologic/Gen-Probe
  • Illumina
  • Kreatech
  • Li-Cor Biosciences
  • Life Technologies/Thermo Fisher
  • Monogram Biosciences
  • Myriad Genetics
  • Nanogen/Elitech
  • Orchid CellMark
  • Ortho-Clinical Diagnostics
  • Proteome Sciences
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • Shimadzu
  • Siemens
  • Sierra Molecular
  • Takara Bio
  • Tecan Group

Appendixes

List of Tables

  • Oncogenes Potential Applications in Cancer Diagnosis
  • Major Companies Developing or Marketing Cancer Molecular Diagnostic Tests
  • Major Companies Developing or Marketing Molecular Diagnostic Tests For Genetic Diseases
  • France, Laboratories Performing DNA Sequencing By Market Segment
  • France, Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
  • France, Molecular Diagnostic Test Volume Forecast By Major Application
  • France, Molecular Diagnostics Market Forecast By Major Application
  • France, Molecular Diagnostics Market By Major Supplier
  • Germany, Laboratories Performing DNA Sequencing by Market Segment
  • Germany, Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
  • Germany, Molecular Diagnostic Test Volume Forecast By Major Application
  • Germany, Molecular Diagnostic Market Forecast By Major Application
  • Germany, Molecular Diagnostics Market by Major Supplier
  • Italy, Laboratories Performing DNA Sequencing by Market Segment
  • Italy, Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
  • Italy, Molecular Diagnostic Test Volume Forecast By Major Application
  • Italy, Molecular Diagnostic Market Forecast By Major Application
  • Italy, Molecular Diagnostics Market By Major Supplier
  • Spain, Laboratories Performing DNA Sequencing by Market Segment
  • Spain, Molecular Diagnostics Market, Potential Laboratory Universe by Market Segment
  • Spain, Molecular Diagnostic Test Volume Forecast By Major Application
  • Spain, Molecular Diagnostic Market Forecast By Major Application
  • Spain, Molecular Diagnostics Market By Major Supplier
  • U.K., Laboratories Performing DNA Sequencing by Market Segment
  • U.K., Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
  • U.K., Molecular Diagnostic Test Volume Forecast By Major Application
  • U.K., Molecular Diagnostic Market Forecast By Major Application
  • U.K., Molecular Diagnostics Market by Major Supplier
Back to Top